Filings For: Bio Green Med Solution, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics
GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Bio Green Med Solution, Inc. (BGMS) 8/14/2026 4:42:28 PM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Rev: $336,000 +16,700.0% Assets $7,854,000 EPS -$0.08
Bio Green Med Solution, Inc. (BGMS) 8/14/2026 6:12:11 AM   View Financials Earnings SEC 2Q 2026 Rev $336,000 +16,700.0% Assets $7,854,000 EPS -$0.08 Export Earnings Model
Bio Green Med Solution, Inc. (BGMS) 5/15/2026 4:34:39 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Rev: $778,000 +12,866.7% Assets $7,564,000 EPS -$0.04
Bio Green Med Solution, Inc. (BGMS) 5/14/2026 4:26:19 PM   View Financials Earnings SEC 1Q 2026 Rev $778,000 +12,866.7% Assets $7,564,000 EPS -$0.04 Export Earnings Model
Bio Green Med Solution, Inc. (BGMS) 5/1/2026 4:36:59 PM   View Proxy SEC Y 2025
Bio Green Med Solution, Inc. (BGMS) 4/27/2026 4:48:04 PM   View Proxy SEC Y 2025
Bio Green Med Solution, Inc. (BGMS) 3/30/2026 6:26:34 PM   View Financials Earnings SEC Y 2025 Rev $666,000 Assets $8,185,000 EPS -$3.59 Export Earnings Model
Bio Green Med Solution, Inc. (BGMS) 3/30/2026 5:56:57 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Rev: $747,000 +1,637.2% Assets $8,185,000 EPS -$6.45
Bio Green Med Solution, Inc. (BGMS) 11/26/2025 5:11:28 PM Micro View Financials 10-K/A SEC Y 2024 ending: 12/31/2024 Rev: $43,000 -89.8% Assets $4,094,000 EPS -$504.30
Bio Green Med Solution, Inc. (BGMS) 11/13/2025 5:16:30 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Rev: $81,000 +710.0% Assets $8,158,000 EPS -$1.31
Bio Green Med Solution, Inc. (BGMS) 11/13/2025 4:50:59 PM   View Financials Earnings SEC 3Q 2025 Rev $81,000 +710.0% Assets $8,158,000 EPS -$1.31 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/14/2025 6:17:27 AM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Rev: $2,000 -50.0% Assets $4,401,000 EPS -$0.98
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/13/2025 5:28:24 PM   View Financials Earnings SEC 2Q 2025 Rev $2,000 -50.0% Assets $4,401,000 EPS -$0.98 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 7/7/2025 5:45:26 PM   View Proxy SEC Y 2024
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/23/2025 5:04:12 PM   View Proxy SEC Y 2024
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/15/2025 4:07:08 PM   View Financials Earnings SEC 1Q 2025 Rev $6,000 -79.3% Assets $3,734,000 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2025 4:23:18 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Rev: $6,000 -79.3% Assets $3,734,000
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/24/2025 3:10:51 PM   View Proxy SEC Y 2024
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/3/2025 4:06:55 PM   View Proxy SEC Y 2024
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/2/2025 5:14:50 PM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024 Rev: $43,000 -89.8% Assets $4,094,000 EPS -$504.30
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/2/2025 4:44:08 PM   View Financials Earnings SEC Y 2024 Rev $0 Assets $4,094,000 EPS -$502.26 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 1/21/2025 6:03:40 AM   View Proxy SEC Y 2024
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2024 5:20:59 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Rev: $10,000 -37.5% Assets $5,381,000
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2024 5:01:11 PM   View Financials Earnings SEC 3Q 2024 Rev $10,000 -37.5% Assets $5,381,000 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/14/2024 5:16:31 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Rev: $4,000 -98.9% Assets $8,190,000 EPS -$0.72
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/14/2024 4:19:25 PM   View Financials Earnings SEC 2Q 2024 Rev $4,000 -98.9% Assets $8,190,000 EPS -$0.72 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2024 5:29:03 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Rev: $29,000 Assets $6,165,000 EPS -$2.27
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2024 4:06:53 PM   View Financials Earnings SEC 1Q 2024 Rev $29,000 Assets $6,165,000 EPS -$2.27 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/8/2024 6:03:58 AM   View Proxy SEC Y 2023
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/29/2024 5:19:57 PM Micro View Financials 10-K/A SEC Y 2023 ending: 12/31/2023 Rev: $420,000 Assets $8,805,000 EPS -$26.75
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/21/2024 5:16:12 PM Micro View Financials 10-K SEC Y 2023 ending: 12/31/2023 Rev: $420,000 Assets $8,805,000 EPS -$26.75
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/19/2024 4:17:34 PM   View Financials Earnings SEC Y 2023 Rev $31,000 Assets $8,805,000 EPS -$25.36 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/29/2023 6:19:34 AM Micro View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Rev: $16,000 Assets $12,497,000 EPS -$0.48
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/29/2023 6:19:34 AM Micro View Financials 10-K/A SEC Y 2022 ending: 12/31/2022 Assets $28,050,000 EPS -$27.24
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/14/2023 8:01:16 PM   View Proxy SEC Y 2022
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/13/2023 4:09:25 PM   View Financials Earnings SEC 3Q 2023 Rev $16,000 Assets $12,497,000 EPS -$0.48 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/10/2023 5:14:40 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Rev: $373,000 Assets $16,991,000 EPS -$0.44
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/9/2023 4:08:00 PM   View Financials Earnings SEC 2Q 2023 Rev $373,000 Assets $16,991,000 EPS -$0.44 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/11/2023 5:34:17 PM Micro View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Assets $22,609,000 EPS -$7.00
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/11/2023 4:08:55 PM   View Financials Earnings SEC 1Q 2023 Rev $0 Assets $22,609,000 EPS -$7.00 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/28/2023 5:34:58 PM   View Proxy SEC Y 2022
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/8/2023 5:17:47 PM Micro View Financials 10-K SEC Y 2022 ending: 12/31/2022 Assets $28,050,000 EPS -$27.24
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/6/2023 4:12:32 PM   View Financials Earnings SEC Y 2022 Rev $0 Assets $28,050,000 EPS -$25.95 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/10/2022 4:27:33 PM Micro View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Assets $31,570,000 EPS -$0.42
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/9/2022 4:30:49 PM   View Financials Earnings SEC 3Q 2022 Rev $0 Assets $31,570,000 EPS -$0.42 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/16/2022 8:18:03 AM Micro View Financials 10-Q/A SEC 2Q 2022 ending: 6/30/2022 Assets $35,895,000 EPS -$0.46
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/11/2022 5:37:02 PM Micro View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Assets $35,895,000 EPS -$0.46
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/10/2022 4:17:18 PM   View Financials Earnings SEC 2Q 2022 Rev $0 Assets $35,895,000 EPS -$0.46 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2022 4:17:56 PM Micro View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Assets $40,178,000 EPS -$0.42
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/11/2022 4:15:54 PM   View Financials Earnings SEC 1Q 2022 Rev $0 Assets $40,178,000 EPS -$0.42 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/26/2022 5:21:17 PM   View Proxy SEC Y 2021
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/30/2022 5:07:28 PM Micro View Financials 10-K SEC Y 2021 ending: 12/31/2021 Assets $43,136,000 EPS -$2.09
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/28/2022 4:19:26 PM   View Financials Earnings SEC Y 2021 Rev $0 Assets $43,136,000 EPS -$0.51 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2021 4:15:54 PM Micro View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Assets $45,293,000 EPS -$0.51
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/10/2021 4:13:20 PM   View Financials Earnings SEC 3Q 2021 Rev $0 Assets $45,293,000 EPS -$0.51 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/12/2021 5:05:53 PM Micro View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Assets $46,334,000 EPS -$0.56
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/11/2021 4:18:08 PM   View Financials Earnings SEC 2Q 2021 Rev $0 Assets $46,334,000 EPS -$0.56 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2021 4:13:58 PM Micro View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Assets $51,817,000 EPS -$0.50
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2021 4:22:37 PM   View Financials Earnings SEC 1Q 2021 Rev $0 Assets $51,817,000 EPS -$0.50 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/29/2021 4:05:48 PM   View Proxy SEC Y 2020
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/1/2021 9:24:37 AM Micro View Financials 10-K SEC Y 2020 ending: 12/31/2020 Assets $36,802,000 EPS -$3.42
Cyclacel Pharmaceuticals, Inc. (BGMS) 2/25/2021 4:35:33 PM   View Financials Earnings SEC Y 2020 Rev $0 Assets $36,802,000 EPS -$1.61 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2020 5:22:19 PM Micro View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Assets $27,213,000 EPS -$0.47
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2020 8:48:46 AM   View Financials Earnings SEC 3Q 2020 Rev $0 Assets $27,213,000 EPS -$0.47 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/13/2020 5:24:20 PM Micro View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020 Assets $29,171,000 EPS -$0.58
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/12/2020 4:18:15 PM   View Financials Earnings SEC 2Q 2020 Rev $0 Assets $29,171,000 EPS -$0.58 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2020 5:22:49 PM Micro View Financials 10-Q SEC 1Q 2020 ending: 3/31/2020 Assets $12,987,000 EPS -$1.48
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2020 4:19:19 PM   View Financials Earnings SEC 1Q 2020 Assets $12,987,000 EPS -$1.48 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2020 4:02:29 PM   View Proxy SEC Y 2019
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/5/2020 5:14:00 PM Micro View Financials 10-K SEC Y 2019 ending: 12/31/2019 Assets $15,308,000 EPS -$9.84
Cyclacel Pharmaceuticals, Inc. (BGMS) 2/26/2020 4:18:04 PM   View Financials Earnings SEC Y 2019 Assets $15,308,000 EPS -$2.76 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/13/2019 5:26:54 PM Micro View Financials 10-Q SEC 3Q 2019 ending: 9/30/2019 Assets $17,077,000 EPS -$2.27
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/13/2019 4:13:19 PM   View Financials Earnings SEC 3Q 2019 Assets $17,077,000 EPS -$2.27 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 9/27/2019 6:05:43 AM   View Proxy SEC Y 2018
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/13/2019 5:24:36 PM Micro View Financials 10-Q SEC 2Q 2019 ending: 6/30/2019 Assets $19,464,000 EPS -$2.13
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/13/2019 4:13:04 PM   View Financials Earnings SEC 2Q 2019 Assets $19,464,000 EPS -$2.13 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2019 5:26:08 PM Micro View Financials 10-Q SEC 1Q 2019 ending: 3/31/2019 Assets $21,510,000 EPS -$2.77
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2019 4:20:14 PM   View Financials Earnings SEC 1Q 2019 Assets $21,510,000 EPS -$2.77 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/10/2019 5:23:29 PM   View Proxy SEC Y 2018
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/28/2019 4:50:52 PM Micro View Financials 10-K SEC Y 2018 ending: 12/31/2018 Rev: $150,000 Assets $19,823,000 EPS -$0.62
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/27/2019 4:19:16 PM   View Financials Earnings SEC Y 2018 Rev $150,000 Assets $19,823,000 EPS -$0.17 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/13/2018 4:22:32 PM Micro View Financials 10-Q SEC 3Q 2018 ending: 9/30/2018 Assets $20,707,000 EPS -$0.18
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/13/2018 6:14:28 AM   View Financials Earnings SEC 3Q 2018 Rev $0 Assets $20,707,000 EPS -$0.18 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/9/2018 5:27:02 PM Micro View Financials 10-Q SEC 2Q 2018 ending: 6/30/2018 Assets $22,730,000 EPS -$0.16
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/9/2018 4:21:10 PM   View Financials Earnings SEC 2Q 2018 Rev $0 Assets $22,730,000 EPS -$0.16 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2018 5:39:32 PM Micro View Financials 10-Q SEC 1Q 2018 ending: 3/31/2018 Assets $24,777,000 EPS -$0.12
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2018 4:14:57 PM   View Financials Earnings SEC 1Q 2018 Rev $0 Assets $24,777,000 EPS -$0.12 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/12/2018 4:47:09 PM   View Proxy SEC Y 2017
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/30/2018 4:46:13 PM Micro View Financials 10-K SEC Y 2017 ending: 12/31/2017 Assets $26,003,000 EPS -$1.95
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/28/2018 4:16:48 PM   View Financials Earnings SEC Y 2017 Rev $0 Assets $26,003,000 EPS $0.11 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/13/2017 6:24:15 AM Micro View Financials 10-Q SEC 3Q 2017 ending: 9/30/2017 Assets $27,851,000 EPS -$0.91
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/9/2017 4:10:29 PM   View Financials Earnings SEC 3Q 2017 Rev $0 Assets $27,851,000 EPS -$0.91 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/10/2017 5:02:41 PM Micro View Financials 10-Q SEC 2Q 2017 ending: 6/30/2017 Assets $16,083,000 EPS -$0.50
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/9/2017 4:30:21 PM   View Financials Earnings SEC 2Q 2017 Rev $0 Assets $16,083,000 EPS -$0.50 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2017 4:25:02 PM Micro View Financials 10-Q SEC 1Q 2017 ending: 3/31/2017 Assets $17,073,000 EPS -$0.38
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/11/2017 4:15:36 PM   View Financials Earnings SEC 1Q 2017 Rev $0 Assets $17,073,000 EPS -$0.38 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/12/2017 4:34:14 PM   View Proxy SEC Y 2016
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/31/2017 5:03:22 PM Micro View Financials 10-K SEC Y 2016 ending: 12/31/2016 Rev: $1,686,000 -13.3% Assets $19,662,000 EPS -$3.50
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/28/2017 4:15:20 PM   View Financials Earnings SEC Y 2016 Rev $1,120,000 +166.0% Assets $19,662,000 EPS -$0.61 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/14/2016 5:20:37 PM Micro View Financials 10-Q SEC 3Q 2016 ending: 9/30/2016 Rev: $205,000 -71.3% Assets $22,652,000 EPS -$0.86
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/14/2016 4:16:14 PM   View Financials Earnings SEC 3Q 2016 Rev $205,000 -71.3% Assets $22,652,000 EPS -$0.86 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/11/2016 5:01:47 PM Micro View Financials 10-Q SEC 2Q 2016 ending: 6/30/2016 Rev: $222,000 -25.0% Assets $18,877,000 EPS -$1.01
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/10/2016 4:15:24 PM   View Financials Earnings SEC 2Q 2016 Rev $222,000 -25.0% Assets $18,877,000 EPS -$1.01 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/13/2016 4:06:58 PM Micro View Financials 10-Q SEC 1Q 2016 ending: 3/31/2016 Rev: $278,000 -72.9% Assets $21,461,000 EPS -$1.04
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/11/2016 4:16:42 PM   View Financials Earnings SEC 1Q 2016 Rev $278,000 -72.9% Assets $21,461,000 EPS -$1.04 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/11/2016 5:23:56 PM   View Proxy SEC Y 2015
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/29/2016 4:59:57 PM Micro View Financials 10-K SEC Y 2015 ending: 12/31/2015 Rev: $1,944,000 +12.1% Assets $24,764,000 EPS -$5.36
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/24/2016 4:18:29 PM   View Financials Earnings SEC Y 2015 Rev $421,000 +70.4% Assets $24,764,000 EPS -$1.16 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2015 5:08:13 PM Micro View Financials 10-Q SEC 3Q 2015 ending: 9/30/2015 Rev: $715,000 -2.7% Assets $27,049,000 EPS -$0.95
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2015 4:10:39 PM   View Financials Earnings SEC 3Q 2015 Rev $715,000 -2.7% Assets $27,049,000 EPS -$0.95 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/12/2015 4:32:53 PM Micro View Financials 10-Q SEC 2Q 2015 ending: 6/30/2015 Rev: $296,000 -58.4% Assets $30,788,000 EPS -$1.19
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/11/2015 4:06:06 PM   View Financials Earnings SEC 2Q 2015 Rev $296,000 -58.4% Assets $30,788,000 EPS -$1.19 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2015 5:16:11 PM Micro View Financials 10-Q SEC 1Q 2015 ending: 3/31/2015 Rev: $1,024,000 +29.3% Assets $35,357,000 EPS -$0.19
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2015 4:13:31 PM   View Financials Earnings SEC 1Q 2015 Rev $1,024,000 +29.3% Assets $35,357,000 EPS -$0.19 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/7/2015 5:00:41 PM   View Proxy SEC Y 2014
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/31/2015 5:10:18 PM Micro View Financials 10-K SEC Y 2014 ending: 12/31/2014 Rev: $1,734,000 -20.0% Assets $29,387,000 EPS -$0.89
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/24/2015 4:17:03 PM   View Financials Earnings SEC Y 2014 Rev $247,000 -58.7% Assets $29,387,000 EPS -$0.21 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2014 5:15:04 PM Micro View Financials 10-Q SEC 3Q 2014 ending: 9/30/2014 Rev: $735,000 +18.9% Assets $31,630,000 EPS -$0.22
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2014 9:11:59 AM   View Financials Earnings SEC 3Q 2014 Rev $735,000 +18.9% Assets $31,630,000 EPS -$0.22 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/12/2014 5:03:53 PM Micro View Financials 10-Q SEC 2Q 2014 ending: 6/30/2014 Rev: $712,000 +34.8% Assets $37,610,000 EPS -$0.22
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/12/2014 4:17:08 PM   View Financials Earnings SEC 2Q 2014 Rev $712,000 +34.8% Assets $37,610,000 EPS -$0.22 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/13/2014 5:29:05 PM Micro View Financials 10-Q SEC 1Q 2014 ending: 3/31/2014 Rev: $792,000 +273.6% Assets $33,785,000 EPS -$0.25
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/13/2014 5:07:06 PM   View Financials Earnings SEC 1Q 2014 Rev $792,000 +273.6% Assets $33,785,000 EPS -$0.25 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/2/2014 5:28:14 PM   View Proxy SEC Y 2013
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/26/2014 5:26:17 PM Micro View Financials 10-K SEC Y 2013 ending: 12/31/2013 Rev: $2,168,000 +3,042.0% Assets $35,520,000 EPS -$1.28
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/25/2014 4:05:28 PM   View Financials Earnings SEC Y 2013 Rev $598,000 +11,860.0% Assets $35,520,000 EPS -$0.13 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/14/2013 5:25:47 PM Micro View Financials 10-Q SEC 3Q 2013 ending: 9/30/2013 Rev: $618,000 +1,526.3% Assets $37,989,000 EPS -$0.32
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2013 4:07:24 PM   View Financials Earnings SEC 3Q 2013 Rev $618,000 +1,526.3% Assets $37,989,000 EPS -$0.32 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/14/2013 5:49:19 PM Micro View Financials 10-Q SEC 2Q 2013 ending: 6/30/2013 Rev: $528,000 +261.6% Assets $37,510,000 EPS $0.10
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/14/2013 5:43:16 PM   View Financials Earnings SEC 2Q 2013 Rev $528,000 +261.6% Assets $37,510,000 EPS $0.10 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/13/2013 5:15:53 PM Micro View Financials 10-Q SEC 1Q 2013 ending: 3/31/2013 Rev: $212,000 +31.7% Assets $17,486,000 EPS -$1.18
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/13/2013 4:05:46 PM   View Financials Earnings SEC 1Q 2013 Rev $212,000 +31.7% Assets $17,486,000 EPS -$1.18 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/3/2013 4:35:44 PM   View Proxy SEC Y 2012
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/1/2013 4:58:22 PM Micro View Financials 10-K SEC Y 2012 ending: 12/31/2012 Rev: $69,000 Assets $19,354,000 EPS -$1.68
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/27/2013 4:03:33 PM   View Financials Earnings SEC Y 2012 Rev $5,000 Assets $19,354,000 EPS -$0.59 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/16/2012 4:00:48 PM Micro View Financials 10-Q SEC 3Q 2012 ending: 9/30/2012 Rev: $38,000 -76.8% Assets $20,526,000 EPS -$0.25
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/13/2012 6:07:34 AM   View Financials Earnings SEC 3Q 2012 Rev $38,000 -76.8% Assets $20,526,000 EPS -$0.25 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/14/2012 4:42:15 PM Micro View Financials 10-Q SEC 2Q 2012 ending: 6/30/2012 Rev: $146,000 -13.1% Assets $21,802,000 EPS -$0.06
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/14/2012 4:10:44 PM   View Financials Earnings SEC 2Q 2012 Rev $146,000 -13.1% Assets $21,802,000 EPS -$0.06 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/15/2012 4:02:49 PM Micro View Financials 10-Q SEC 1Q 2012 ending: 3/31/2012 Rev: $161,000 -16.1% Assets $25,338,000 EPS -$0.40
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2012 4:07:10 PM   View Financials Earnings SEC 1Q 2012 Rev $161,000 -16.1% Assets $25,338,000 EPS -$0.40 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/19/2012 3:27:15 PM   View Proxy SEC Y 2011
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/30/2012 4:00:00 PM Micro View Financials 10-K SEC Y 2011 ending: 12/31/2011 Assets $25,998,000 EPS -$2.22
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/29/2012 4:09:07 PM   View Financials Earnings SEC Y 2011 Rev ($524,000) Assets $25,998,000 EPS -$0.49 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/14/2011 4:44:06 PM Micro View Financials 10-Q SEC 3Q 2011 ending: 9/30/2011 Rev: $164,000 +3.1% Assets $28,946,000 EPS -$0.47
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/14/2011 4:15:32 PM   View Financials Earnings SEC 3Q 2011 Rev $164,000 +3.1% Assets $28,946,000 EPS -$0.47 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/12/2011 3:24:56 PM Micro View Financials 10-Q SEC 2Q 2011 ending: 6/30/2011 Rev: $168,000 +41.2% Assets $22,695,000 EPS -$0.08
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/11/2011 4:20:39 PM   View Financials Earnings SEC 2Q 2011 Rev $168,000 +41.2% Assets $22,695,000 EPS -$0.08 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/12/2011 4:05:45 PM   View Financials Earnings SEC 1Q 2011 Rev $192,000 EPS -$0.10 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/26/2011 6:36:45 PM   View Proxy SEC Y 2010
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/23/2011 12:00:00 AM   View Financials Earnings SEC Y 2010 Rev ($436,000) Assets $31,459,000 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/12/2010 12:00:00 AM   View Financials Earnings SEC 3Q 2010 Rev $159,000 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 9/21/2010 2:11:21 PM   View Proxy SEC Y 2009
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/5/2010 12:00:00 AM   View Financials Earnings SEC 2Q 2010 Rev $119,000 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/13/2010 12:00:00 AM   View Financials Earnings SEC Y 2009 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/23/2010 5:28:51 PM   View Proxy SEC Y 2009
Cyclacel Pharmaceuticals, Inc. (BGMS) 3/23/2010 12:00:00 AM   View Financials Earnings SEC Y 2009 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 11/3/2009 12:00:00 AM   View Financials Earnings SEC 3Q 2009 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 8/6/2009 12:00:00 AM   View Financials Earnings SEC 2Q 2009 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 5/14/2009 12:00:00 AM   View Financials Earnings SEC 1Q 2009 Export Earnings Model
Cyclacel Pharmaceuticals, Inc. (BGMS) 4/30/2009 1:39:51 PM   View Proxy SEC Y 2008